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Abstract
Objective:  To  prospectively  analyze  the  prognostic  factors  for  neurological  complications  of
childhood  bacterial  meningitis.
Methods: This  prospective  study  enrolled  77  children  from  1  month  until  16  years  of  age,  treated
for bacterial  meningitis  during  the  period  of  January  1,  2009  through  December  31,  2010.  16
relevant  predictors  were  chosen  to  analyze  their  association  with  the  incidence  of  neurological
complications.  p-values  <  0.05  were  considered  statistically  signiﬁcant.
Results: Of  the  77  children  treated  for  bacterial  meningitis,  33  patients  developed  neurological
complications (43%),  and  two  children  died  (2.6%).  The  etiology  of  bacterial  meningitis  cases  was
proven  in  57/77  (74%)  cases:  32  meningococci,  eight  pneumococci,  six  Gram-negative  bacilli,
ﬁve  H.  inﬂuenzae,  ﬁve  staphylococci,  and  one  S.  viridans  isolates  were  found.  Factors  found
to  be  associated  with  increased  risk  of  development  of  neurological  complications  were  age  <
12  months,  altered  mental  status,  seizures  prior  to  admission,  initial  therapy  with  two  antibi-
otics,  dexamethasone  use,  presence  of  focal  neurological  deﬁcit  on  admission  and  increased
proteins  in  cerebrospinal  ﬂuid  (CSF)  (p  <  0.05).  Initial  pleocytosis  >  5,000  cells/mm3,  pleocyto-
sis  >  5,000  cells/mm3 after  48  hours,  CSF/blood  glucose  ratio  <  0.20,  female  gender,  previous
treatment with  antibiotics,  community-acquired  infection,  duration  of  illness  >  48  hours,  pres-
ence  of  comorbidity,  and  primary  focus  of  infection  were  not  associated  with  increased  risk  for
the  development  of  neurological  complications.
Conclusion:  Age  <  12  months  and  severity  of  clinical  presentation  at  admission  were  identiﬁed
as the  strongest  predictors  of  neurological  complications  and  may  be  of  value  in  selecting
patients  for  more  intensive  care  and  treatment.
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Estudo  prospectivo  dos  fatores  de  risco  para  complicac¸ões  neurológicas  na  meningite
bacteriana  infantil
Resumo
Objetivo:  Análise  prospectiva  de  fatores  de  prognóstico  para  complicac¸ões  neurológicas  da
meningite  bacteriana  infantil.
Métodos: Este  estudo  prospectivo  recrutou  77  crianc¸as  de  um  mês  a  16  anos  de  idade  tratadas  de
meningite  bacteriana  durante  o  período  de  1/1/2009  a  31/12/2010.  Foram  escolhidos  16  pred-
itores  relevantes  para  analisar  sua  associac¸ão  com  a  incidência  de  complicac¸ões  neurológicas.
Valores  de  p  abaixo  de  0,05  foram  considerados  estatisticamente  signiﬁcativos.
Resultados: Das  77  crianc¸as  tratadas  para  meningite  bacteriana,  desenvolveram-se
complicac¸ões  neurológicas  em  33  pacientes  (43%),  e  duas  crianc¸as  morreram  (2,6%).  A
etiologia  dos  casos  de  meningite  bacteriana  foi  comprovada  em  57/77  (74%)  dos  casos:  foram
encontrados  32  isolados  de  meningococos;  8  de  pneumococos;  6  de  bacilos  gram-negativos;  5
de  H.  inﬂuenzae;  5  de  estaﬁlococos  e  1  de  S.  viridans.  Os  fatores  que  se  mostraram  associados
a  aumento  do  risco  de  desenvolvimento  de  complicac¸ões  neurológicas  foram  idade  <  12
meses,  alterac¸ão  do  estado  mental,  crises  convulsivas  antes  da  admissão,  terapia  inicial  com
dois  antibióticos,  uso  de  dexametasona,  presenc¸a de  déﬁcit  neurológico  focal  na  admissão
e  aumento  das  proteínas  do  líquido  cerebrospinal  (LCS)  (p  <  0,05).  Pleiocitose  inicial  >  5.000
células/mm3,  pleiocitose  >  5.000  células/mm3 depois  de  48  horas,  baixa  relac¸ão  da  glicose  no
LCS/sangue  <  0,20,  gênero  feminino,  tratamento  prévio  com  antibióticos,  infecc¸ão  adquirida
na  comunidade,  durac¸ão  da  doenc¸a >  48  horas,  presenc¸a de  comorbidade  e  foco  primário
de infecc¸ão  não  se  associaram  a  aumento  do  risco  para  o  desenvolvimento  de  complicac¸ões
neurológicas.
Conclusão: Idade  inferior  a  12  meses  e  gravidade  da  apresentac¸ão  clínica  na  admissão  foram
identiﬁcadas como  os  preditores  mais  fortes  de  complicac¸ões  neurológicas  e  podem  ter  valor
para  selecionar  pacientes  para  tratamento  mais  intensivo.
©  2013  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  
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Este é um artigo Open Access sob a licença de CC BY-NC-NDIntroduction
Despite  the  development  of  antibiotics  that  are  more  effec-
tive in  treating  bacterial  meningitis,  the  mortality  rates
continue to  be  high,  ranging  between  5%  and  30%,  while  as
many as  50%  of  survivors  experience  neurological  sequelae,
such as  hearing  impairment,  seizure  disorders,  and  learning
and behavioral  problems.1--12 The  neurological  complications
resulting from  bacterial  meningitis  include  subdural  effu-
sions or  empyemas,  cerebral  abscesses,  focal  neurological
deﬁcits (e.g.,  hearing  loss,  cranial  nerve  palsies,  hemi-
paresis, or  quadriparesis),  hydrocephalus,  cerebrovascular
abnormalities, altered  mental  status,  and  seizures.  Acute
bacterial meningitis  is  more  common  in  resource-poor  than
resource-rich settings.3 The  occurrence  of  negative  conse-
quences of  bacterial  meningitis  in  developed  countries  is
strongly reduced  by  vaccination  strategies,  antibiotic  treat-
ment, and  good  care  facilities.1,4,5 The  speed  of  diagnosis,
the identiﬁcation  of  the  causative  pathogen,  and  the  ini-
tial antimicrobial  therapy  represent  important  factors  for
the prognosis  of  bacterial  meningitis  in  children.  Develop-
ing countries  such  as  Kosovo  are  still  facing  cases  of  bacterial
meningitis in  children  due  to  non-implementation  of  vacci-
nation programs  against  meningeal  pathogens.  Furthermore,
the shortage  of  antibiotics  in  hospitals  makes  it  difﬁcult  to
follow guidelines  for  the  initial  empirical  therapy  of  chil-
dren with  bacterial  meningitis.  Late  and  insufﬁcient  results
of cerebrospinal  ﬂuid  (CSF)  cultures  and  Gram-staining  make
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areatment  more  difﬁcult,  particularly  in  cases  with  neuro-
ogical complications.
From previous  reports  in  Kosovo,  the  mortality  rate  of
hildren with  bacterial  meningitis  was  5.4%,  while  neurologi-
al complications  were  reported  in  22%  of  cases.10 During  the
ears of  the  present  study,  the  annual  incidence  of  bacterial
eningitis was  3.0  cases  per  100,000.  Of  the  total  bacte-
ial meningitis  cases  (n  =  126),  77  (63%)  were  children  up  to
6 years  of  age,  while  74%  of  pediatric  bacterial  meningitis
ases occurred  in  children  under  6  years  of  age.
The  aim  of  this  study  was  to  perform  a  prospective  mul-
ivariate analysis  of  statistically  signiﬁcant  predictors  for
eurological complications  of  childhood  bacterial  meningi-
is.
aterial and methods
hildren  aged  between  1  month  and  16  years,  treated
or bacterial  meningitis  at  the  Infectious  Diseases  Clinic
n Prishtina  (University  Clinical  Center  of  Kosovo)  during
he period  from  January  1,  2009  to  December  31,  2010
ere prospectively  enrolled  in  the  study.  The  furthest  dis-
ance from  Prishtina  is  estimated  to  be  <  100  km  or  1.5
our driving.  57  children  had  a conﬁrmed  bacterial  etiology.
0 patients  were  treated  for  probable  bacterial  meningi-
is, based  on  World  Health  Organization  (WHO)  criteria:
linical signs  and  symptoms  of  meningitis,  changes  in  CSF,
nd lack  of  an  identiﬁable  bacterial  pathogen.  Children
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ho  didn’t  fulﬁll  the  criteria  for  bacterial  meningitis  were
xcluded from  the  study.  Cases  of  tuberculous  meningi-
is and  neurobrucellosis,  as  well  as  patients  younger  than
 month  old  were  excluded  from  the  study.  The  follow-
ng procedure  was  performed  on  admission  for  every  child
ith suspected  bacterial  meningitis:  lumbar  puncture,  ﬂuid
nalysis (cell  count  with  differential,  glucose,  protein),
ram-staining, and  bacterial  culture,  repeated  LPs  after
8 hours.  The  treatment  was  followed  by  laboratory  anal-
sis; evaluation  by  a  neurologist,  an  ophthalmologist,  and
n ear,  nose,  and  throat  (ENT)  specialist;  and  brain  imaging
hen indicated.  The  diagnosis  of  neurologic  complications
as made  by  neurologic  examination,  neuroimaging,  elec-
roencephalography, and  by  the  evaluation  of  a  neurologist,
phthalmologist, ENT  specialist,  and  psychologist.  Indica-
ions for  performing  a  computed  tomography  (CT)  of  the
ead after  meningitis  were:  prolonged  fever,  focal  neuro-
ogical deﬁcit,  convulsions,  worsening  consciousness  level,
rolonged  cyto-biochemical  changes  in  CSF,  or  worsening
f clinical  presentation.  The  physicians  of  the  ward  for
reatment of  meningitis,  including  the  ﬁrst  author,  treated
hese children  and  performed  a  one-year  follow  up,  which
ncluded routine  visits  to  the  clinic  and  consultations  by
hone. The  initial  antibiotic  therapy  was  selected  based  on
he clinical  presentation  of  illness  with  prognostic  factors  for
n unfavorable  outcome  (altered  mental  state,  seizures,  and
eurologic deﬁcit);  the  possible  pathogen  for  each  age  group
nd  the  local  antibiotic  resistance  patterns;  duration  of  ill-
ess prior  to  admission;  previous  treatment  with  antibiotics;
he presence  of  a  primary  infectious  focus;  the  identiﬁcation
f a  community-  or  hospital-acquired  infection  (shunt  inter-
ention,  neurosurgery,  etc.);  presentation  of  petechial  skin
ash; underlying  diseases;  antibiotics  available  in  the  ward;
nd the  ﬁnancial  resources  of  the  parents.
Initial  single-agent  antibiotic  therapy  was  used  in  42
hildren (55%),  mainly  ceftriaxone  (36/77,  47%),  while  35
hildren (45%)  were  treated  with  initial  dual-agent  antibi-
tic therapy,  mostly  the  combination  of  ceftriaxone  with
ancomycin (18/77,  23%).  Dexamethasone  was  used  in  66
hildren (86%),  and  criteria  for  its  use  were  clinical  pre-
entation on  admission,  altered  mental  status,  presence  of
eizures, or  focal  neurological  deﬁcit  on  admission.
In  order  to  determine  their  association  with  the  incidence
f neurological  complications  of  bacterial  meningitis  in  chil-
ren treated  in  this  ward,  16  potentially  relevant  predictors
ere chosen  to  be  analyzed.  p-values  <  0.05  were  considered
tatistically signiﬁcant.  There  were  no  missing  data  on  the
6 variables  collected  from  the  medical  records  including:  1)
ge (which  was  later  categorized  into  speciﬁc  age  groups);
) gender;  3)  duration  of  the  patients
′
illness  prior  to  admis-
ion, <  or  >  48  hours;  4)  previous  treatment  with  antibiotics;
) presence  of  altered  mental  status  at  the  time  of  presenta-
ion; 6)  presence  of  focal  neurological  deﬁcits  that  occurred
n the  period  between  the  start  of  symptoms  and  arrival  at
he admission  room  (cranial  nerve  involvement  or  hemipare-
is/quadriparesis); 7)  occurrence  of  seizures  prior  to  admis-
ion; 8)  initial  single-  or  dual-agent  antibiotic  therapy;  9)
se of  dexamethasone;  10)  presence/absence  of  a primary
nfectious focus;  11)  presence/absence  of  comorbidity;  12)
nitial  turbid  CSF  with  pleocytosis  >  5,000  cells/mm3;  13)
leocytosis >  5,000  cells/mm3 after  48  hoursl  14)  CSF/blood
lucose ratio  <  0.20;  15)  increased  proteinorrhachia
a
(
lNamani  S et  al.
>  0.50  g/L);  and  16)  whether  the  infection  was  community-
r hospital-acquired.  Good  outcome  was  considered  treat-
ent without  any  obvious  neurological  complications  at
ischarge, and  adverse  outcome  was  considered  the  man-
festation of  neurological  complications  during  the  course
f illness,  or  death.  There  were  only  two  death  cases  who
anifested neurological  complications  (obstructive  hydro-
ephalus and  cerebral  abscesses),  thus  both  were  included
n the  group  of  children  with  neurological  complications.  All
hildren were  followed-up  for  a  minimum  of  12  months.
This  study  was  approved  by  the  Ethic-Professional  Com-
ittee of  the  University  Clinical  Center  of  Kosova.
tatistical  analysis
ata  were  analyzed  using  Stata  7.1  and  the  Statistical
ackage for  Social  Sciences  (SPSS)  13.  The  statistical  param-
ters analyzed  included  structure  index,  mean,  and  standard
eviation. p-values  <  0.05  were  considered  statistically  sig-
iﬁcant.
esults
uring  the  two-year  study  period,  77  children  aged  between
 month  and  16  years  (57  children  <  6  years;  48/77  males)
ere treated  for  bacterial  meningitis.  57  children  had
 conﬁrmed  bacterial  etiology,  as  follows:  32,  Neisseria
eningitidis; eight,  Streptococcus  pneumoniae;  six,  Gram-
egative bacilli  (three  P.  aeruginosa,  two  E.  coli,  and  one
. pneumonia);  ﬁve,  Haemophilus  inﬂuenzae  type  b;  ﬁve,
taphylococcus aureus;  and  one,  S.  viridans.  20  patients
ere treated  for  probable  bacterial  meningitis,  based
pon the  criteria  mentioned  in  the  Material  and  Methods
ection.
Of the  77  children  treated  for  bacterial  meningitis,
3 developed  neurological  complications  (43%),  and  two
hildren who  presented  with  >  48  hours  of  illness  died  (14-
onth-old child  due  to  S.  pneumoniae  and  1-month-old  child
ue to  Pseudomonas  aeruginosa).
The  neurological  complications  observed  were:  subdu-
al effusion  (22/77;  28.6%);  recurrent  seizures  (6/77;  7.8%);
emiparesis  (5/77;  6.5%);  intracerebral  hemorrhage  (3/77;
.9%); cerebritis  (3/77;  3.9%);  facial  nerve  palsy  (3/77;
.9%); hydrocephalus  (2/77;  2.6%);  and  single  cases  of  sub-
ural hematoma,  cerebral  abscess,  subdural  empyema,  and
urulent ventriculitis  (1.3%).
The  highest  incidence  of  neurological  complications  was
bserved in  children  <  12  months  of  age  (p  <  0.05)  (Table  1).
A  total  of  47  patients  (61%)  were  admitted  with  duration
f illness  <  48  hours.  The  mean  duration  of  illness  was  2.2
ays, and  there  were  no  statistically  signiﬁcant  differences
n duration  of  illness  according  to  age  groups  (p  >  0.05).  A
ower incidence  of  neurological  complications  was  observed
n children  with  duration  of  illness  <  48  hours  (19  patients
40%]), as  compared  to  patients  who  were  admitted  after
wo days  of  illness.  The  observed  differences  were  not  sta-
istically signiﬁcant  (p  >  0.05)  (Table  2).Children  who  had  seizures  prior  to  admission  (n  =  14,  18%)
nd those  who  were  admitted  with  an  altered  mental  status
n =  44,  57%)  were  found  to  have  higher  incidence  of  neuro-
ogical complications  (p  <  0.05).  There  were  no  statistically
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Table  1  Relative  risk  for  neurologic  complications  by  age  group  during  years  2009-2010.
Age  group  n  Patients  with  neurologic  complications  (n)  %  Relative  risk  (95%  CI)
0  -  1  years  28  20  71  2.69  (1.62  -  4.59)
>  1  -  6  years  29  11  38  0.83  (0.46  -  1.4)
>  6  -  16  years  20  2  10  0.18  (0.05  -  0.57)
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rCI, conﬁdence interval.
signiﬁcant  differences  in  presentation  of  seizures,  presence
of neurological  deﬁcit,  or  alteration  of  mental  status  accord-
ing to  age  group.
In addition,  children  who  had  focal  neurological  deﬁcits
at the  time  of  admission  (n  =  13,  17%)  were  found  to  be
at increased  risk  for  developing  neurological  complications
(p <  0.05).
The  incidence  of  neurological  complications  was  higher
in patients  treated  with  dexamethasone,  compared  to  those
who were  not  (p  <  0.05).  The  mean  duration  of  illness  before
dexamethasone use  was  three  days.  Almost  half  of  the
patients (33  children,  49%)  were  previously  treated  with
antibiotics, but  they  were  not  associated  with  increased
incidence of  neurological  complications  (p  >  0.05).
The incidence  of  neurological  complications  was  higher  in
patients who,  during  the  initial  antibiotic  treatment,  were
treated with  two  antibiotics  (n  =  35;  45%),  compared  to  those
treated with  one  antibiotic  (n  =  42;  55%)  (p  <  0.05).
Increased  protein  levels  (mean  1.63  g/L)  were  found  in  65
patients (84%),  who  also  had  higher  incidence  of  neurological
complications (p  <  0.05).
Initial  turbid  CSF  with  pleocytosis  >  5,000  cells/mm3
(n  =  46;  60%)  and  turbid  CSF  with  pleocytosis  >  5,000
cells/mm3 after  48  hours  (n  =  15;  19%)  were  not  associated
o
f
r
k
Table  2  Association  between  various  clinical  factors  and  the  d
bacterial  meningitis.
Nr  Prognostic  factor  Good  out
n  
1  Age  <  12  months  old  8  
2  Altered  mental  status  17  
3  Seizures  prior  to  admission  2  
4  Initial  therapy  with  two  antibiotics  11  
5  Dexamethasone  use  34  
6  Neurological  deﬁcit  at  the  time  of  admission  4  
7  Increased  proteinorrhachia  34  
8  CSF/blood  glucose  ratio  <  0.20  10  
9  Turbid  CSF  after  48  hours  7  
10  Previously  treated  with  antibiotics  20  
11  Community-acquired  infection  41  
12  Duration  of  illness  <  48  hours  28  
13  Presence  of  comorbidity 11  
14  Patients  with  a  primary  focus  of  infection  31  
15  Initial  pleocytosis  >5,000  cells/mm3 26  
16  Female  gender  16  
CSF, cerebrospinal ﬂuid.ith  increased  risk  for  developing  neurological
omplications  (p  >  0.05).
Patients  who  had,  at  the  initial  lumbar  puncture,  a
SF/blood glucose  ratio  <  0.20  were  not  at  increased  risk
or developing  neurological  complications  (p  >  0.05).
The  presence  of  a  primary  infectious  focus  (n  =  53;  69%),
he presence  of  comorbidity  (n  =  18;  23%),  community-
cquired infection  (n  =  73;  95%),  and  female  gender  (n  =  29;
8%)  were  not  associated  with  increased  incidence  of  neu-
ological complications  (p  >  0.05).
The  etiology  of  bacterial  meningitis  cases  was  proven  in
7/77 cases  (74%):  32  meningococci,  eight  pneumococci,
ix Gram-negative  bacilli,  ﬁve  H.  inﬂuenzae  type  B,  ﬁve
taphylococci, and  one  S.  viridans  isolates  were  found.
eurological complications  developed  more  frequently  in
atients who  were  infected  with  S.  pneumoniae  (6/8),  S.
ureus (3/5),  Gram-negative  bacilli  (2/6),  N.  meningitidis
8/32), and  H.  inﬂuenzae  (1/5).
Children  with  bacterial  meningitis  were  equally  from
ural (n  =  39)  and  urban  places  (n  =  38).  A  higher  incidence
f neurological  complications  was  recorded  in  children
rom urban  places  (18/38;  47%)  compared  to  children  from
ural places  (15/39;  38%).  None  of  the  children  attended
indergarten.
evelopment  of  neurological  complications  in  children  with
come  (n  =  44)  Outcome:  neurologic
complications (n  =  33)
p-value
%  n  %
18  20  61  0.00009
39  27  82  0.0001
5  12  36  0.0003
25  24  73  0.001
77  32  97  0.01
9  9  27  0.035
77  31  94  0.045
23  12  36  0.212
16  8  24  0.36
45  18  55  0.43
93  32  97  0.46
64  19  58  0.59
25  7  21  0.69
70  22  67  0.72
59  20  61  0.75
36  13  39  0.79
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iscussion
espite  the  progress  in  medicine,  bacterial  meningitis
auses substantial  morbidity  and  mortality  in  children  in
oth developed1,2,9,11--16 and  developing  countries.6,10,17--20
ensorineural  hearing  loss,  seizures,  motor  problems,  hydro-
ephalus and  mental  retardation,  as  well  as  more  subtle
utcomes like  cognitive,  academic,  and  behavioral  problems
re observed  in  post-meningitis  children.7,9,12,13 Chandran  A.
t al.,  in  their  systematic  literature  search,  found  that  49%
f survivors  of  childhood  bacterial  meningitis  were  reported
o have  one  or  more  long-term  sequelae.  The  majority  of
eported sequelae  were  behavioral  and/or  intellectual  dis-
rders (45%).21 The  risk  of  long  term  sequelae  is  higher  in
ndividuals who  have  acute  neurological  complications  dur-
ng the  course  of  the  disease.6,8 Identiﬁcation  of  predictors
or early  neurological  complications  is  extremely  important,
ince they  are  also  the  ﬁrst  predictors  of  long-term  sequelae
f childhood  bacterial  meningitis.
Several  studies  of  clinical  features  and  prognostic  fac-
ors in  children  with  bacterial  meningitis  have  been
erformed,2,6--8,11--14,17,22,23 and  the  majority  were  conducted
n developed  countries.  In  the  present  study,  the  inﬂuence
f 16  potentially  important  prognostic  factors  for  neuro-
ogical complications  in  children  with  bacterial  meningitis
ere prospectively  analyzed  in  a  developing  country.  Young
ge (indicated  as  younger  than  two  years  old),  is  consid-
red an  important  prognostic  factor  for  adverse  outcome
f children  with  bacterial  meningitis.2,18 In  this  study,  age
 12  months  was  also  identiﬁed  as  predictor  for  neurologi-
al complications.  From  a  previous  report  by  the  authors,
ge <  12  months  was  a  risk  factor  for  both  early  neuro-
ogical complications  and  long-term  sequelae  of  bacterial
eningitis in  children.24
Severity  of  clinical  presentation,  manifested  by  the  alter-
tion of  mental  status  and  the  occurrence  of  seizures,  are
dentiﬁed as  the  strongest  prognostic  factors  for  neuro-
ogical complications  in  the  present  study,  similar  to  that
ndicated in  numerous  studies  from  developed12,14,16,25,26 and
eveloping countries.6,17--20,27,28 Klinger  et  al.  found  that
uration of  seizures  for  >  72  hours  and  presence  of  coma
ere the  most  important  predictors  of  adverse  outcome.25
Time  required  for  establishing  a  diagnosis  of  bacterial
eningitis depends  on  the  ability  of  primary  health  care
ervices to  accurately  assess  the  symptoms  and  to  order
mmediate patient  transfer  to  specialized  institutions  in
hich the  prompt  diagnosis  can  be  conﬁrmed  and  a  suitable
ntimicrobial therapy  can  be  initiated.  Delay  in  treatment
s associated  with  an  increased  risk  of  neurological  dis-
bility and  death  in  both  developed13,22,25 and  developing
ountries.10,17,19,28 In  the  present  study,  duration  of  illness  >
8 hours  was  associated  with  increased  incidence  of  neuro-
ogical complications  in  survivors  compared  to  children  with
uration of  illness  <  48  hours,  but  the  differences  were  not
tatistically signiﬁcant.  The  mean  duration  of  illness  prior  to
dmission was  2.2  days,  which  the  authors  consider  to  be  an
mprovement of  their  health  care  system  and  socioeconomic
onditions compared  to  previous  reports,  where  the  mean
uration of  illness  in  children  with  bacterial  meningitis  was
.7 days.10 Two  other  beneﬁt  factors  are  existence  of  the
pecialized ward  for  treatment  of  CNS  infections  in  children
t the  Infectious  Diseases  Clinic  in  Prishtina  (the  capital  city
o
g
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f  Kosovo)  for  more  than  36  years,  and  that  the  furthest  dis-
ance from  Prishtina  is  estimated  to  be  <  100  km  or  1.5  hours
f driving.
A decade  after  the  war  in  Kosovo  (1999),  many  private
linics opened,  with  no  control  of  which  ﬁrst-line  antibiotics
ere given  to  children.  Most  pediatricians  and  family  doctors
rescribe third  generation  cephalosporins,  especially  cef-
riaxone, as  a  ﬁrst-line  antibiotic  therapy  for  febrile  illness
n children.  Almost  half  of  the  patients  (49%)  were  previ-
usly treated  with  antibiotics,  but  they  were  not  associated
ith an  increased  incidence  of  neurological  complications.
n the  authors’  prior  study,  previous  treatment  with  antibi-
tics was  found  to  be  associated  with  increased  risk  for
eath.10
Children  who  manifested  focal  neurological  deﬁcit  at
dmission had  a  signiﬁcantly  higher  incidence  of  neurologi-
al complications.  Oostenbrik  et  al.  found  that  children  with
cute focal  neurological  symptoms  tend  to  have  the  worst
rognosis.12
The  incidence  of  neurological  complications  was  signiﬁ-
antly higher  in  patients  who  were  initially  treated  with  two
ntibiotics (n  =  35;  45%),  as  those  children  presented  severe
linical presentation  at  admission.  The  most  administered
nitial antibiotic  therapy  was  the  combination  of  ceftriaxone
ith vancomycin  (23%).
Many  clinical  trials  were  undertaken  to  determine  the
ffects of  adjunctive  dexamethasone  on  the  outcome  in
hildren with  bacterial  meningitis.10,16,22,29 The  results,  how-
ver, do  not  point  unequivocally  to  a  beneﬁcial  effect.29,30
n  this  study,  adjunctive  dexamethasone  therapy  did  not
educe the  incidence  of  neurological  complications  in  chil-
ren with  bacterial  meningitis.  The  beneﬁcial  effect  of
examethasone use  could  not  be  proved,  as  a  result  of
everal factors:  dexamethasone  was  used  in  patients  who
resented with  the  severe  clinical  form  of  illness  at  admis-
ion, the  mean  duration  of  illness  prior  to  dexamethasone
se was  three  days,  and  half  of  children  were  previously
reated with  antibiotics.
Other risk  factors  identiﬁed  by  previous  studies  include
lterations in  various  CSF  parameters.  Low  CSF  leukocyte
ount, low  CSF  glucose  level,  low  CSF/blood  glucose  level,
nd high  CSF  protein  level  have  been  identiﬁed  as  sig-
iﬁcant factors  predicting  neurological  complications  of
acterial meningitis  in  children  in  both  developed9,11,13--16,26
nd  developing  countries.17--20,28
In  this  study,  only  increased  CSF  protein  level  was  iden-
iﬁed as  risk  factor  for  neurological  complications.  Initial
urbid CSF  with  pleocytosis  >  5,000  cells/mm3,  turbid  CSF
fter 48  hours,  and  CSF/blood  glucose  ratio  <  0.20  were  not
dentiﬁed as  statistically  signiﬁcant  factors  for  the  develop-
ent of  neurological  complications.
An  association  between  meningitis  caused  by  S.  pneumo-
iae and  unfavorable  evolution  has  been  suggested  in  the
iterature.11--13,16,17,19 According  to  Antoniuk  et  al.,  infection
ith S.  pneumoniae  is  considered  a  risk  factor  for  acute  neu-
ological complication.6 In  the  present  study,  neurological
omplications developed  more  frequently  in  patients  who
ere infected  with  S.  pneumoniae.
Presence  of  a  primary  focus  of  infection,  presence
f comorbidity,  community-acquired  infection,  and  female
ender were  not  found  to  be  associated  with  increased  risk
or the  development  of  neurological  complications.
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The  primary  meningeal  pathogen  involved  in  causing
community-acquired  bacterial  meningitis  in  children  from
Kosovo continues  to  be  N.  meningitidis.  Hib  vaccination
during routine  childhood  immunization  in  Kosovo  has  been
implemented only  since  2010,  giving  hope  to  reduce  the
burden of  bacterial  meningitis  in  children.  The  implemen-
tation of  protocols  for  the  empirical  treatment  of  bacterial
meningitis to  reduce  the  mortality  rate  and  the  incidence  of
neurological complications  is  the  goal  of  future  treatments
of children.
In conclusion,  age  <  12  months  and  severity  of  clinical
presentation at  admission  (alteration  of  mental  status  and
the occurrence  of  seizures)  were  identiﬁed  as  the  strongest
predictors for  neurological  complications,  and  may  be  of
value in  selecting  patients  for  more  intensive  care  and  treat-
ment.
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